Xianyou Ji

Harbin Medical University — China

Medicine · Health Sciences

3h-index41citations7works6.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lipoproteins and Cardiovascular Health(4), Health Systems, Economic Evaluations, Quality of Life(2), Cancer, Lipids, and Metabolism(2), Diabetes, Cardiovascular Risks, and Lipoproteins(1), Acute Myocardial Infarction Research(1)

Publications7 total

Efficacy and Safety of HSK31679 in Asian Patients With MASLD: A Randomized Controlled Trial
Clinical Gastroenterology and Hepatology·2025
Multiply doses of FDC of rosuvastatin and ezetimibe versus rosuvastatin monotherapy in Chinese patients with hypercholesterolemia (ROSE-CH): multicenter, randomized-controlled trial
Lipids in Health and Disease·2025Open Access
Efficacy and safety of Shuxuening injection in patients with unstable angina: a multicenter, randomized, placebo-controlled trial
Phytomedicine·2025Open Access
LBP-045 Efficacy and safety of HSK31679, a thyroid hormone receptor β agonist, for the treatment of asian non-alcoholic fatty liver disease: a multicenter randomized, double-blind, placebo-controlled, phase 2a trial
Journal of Hepatology·2024· 27 cited
Efficacy and Safety of Ongericimab in Chinese Patients With Primary Hypercholesterolemia and Mixed Dyslipidemia
Journal of the American Heart Association·2024· 10 citedOpen Access
Efficacy and safety of ongericimab given by prefilled syringe or autoinjector in primary hypercholesterolemia and mixed hyperlipidemia
Nutrition Metabolism and Cardiovascular Diseases·2024· 4 cited
Abstract 11893: Efficacy and Safety of Ongericimab in Chinese Patients With Primary Hypercholesterolemia and Mixed Dyslipidemia
Circulation·2023

Frequent Co-authors

Zhaohui Pei(4), Zhifeng Cheng(3), Zhouqing Huang(3), Gaopin Wang(3), Yi Zhao(3), Jixian Gao(2), Wei Yue(2), Peili Bu(2), Qincong Chen(2), Jianlong Sheng(2), Chuanwu Zhu(2), Bihui Zhong(2), Jianming Zhang(2), Le Wang(2), Qingxian Cai(2), Lvfeng Yao(2), Lingchun Lv(2), Yanhang Gao(2), Bihua Xia(2), Laijing Du(2)